NCT06246539

Brief Summary

Burnout shares symptoms with anxiety and depression. While there is no single intervention for burnout, there are validated interventions (which are amenable to virtual reality (VR)) for anxiety and depression. UMassMemorial data from the Professional Well-Being Academic Consortium show that MD burnout and distress has increased since 2020. The investigators believe providing clinicians with a unique tool (VR) will be a feasible and efficacious way to tackle distress. It is known that only 1% of our MDs have done mindfulness training but nearly 50% are interested in doing so. Therefore, a self-administrable, interactive mindfulness program delivered over VR has great potential to reach clinicians who want to practice a more active form of mindfulness at a time convenient to them. The results of the study will provide preliminary evidence to determine if a take-home VR mindfulness program decreases clinician stress.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
32

participants targeted

Target at P25-P50 for not_applicable

Timeline
26mo left

Started Jun 2026

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 30, 2024

Completed
8 days until next milestone

First Posted

Study publicly available on registry

February 7, 2024

Completed
2.3 years until next milestone

Study Start

First participant enrolled

June 1, 2026

Expected
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2027

1.2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

July 31, 2028

Last Updated

March 13, 2026

Status Verified

September 1, 2025

Enrollment Period

1 year

First QC Date

January 30, 2024

Last Update Submit

March 11, 2026

Conditions

Outcome Measures

Primary Outcomes (9)

  • PROMIS - anxiety

    PROMIS Short Form - anxiety scale. Scores of 8-40; Higher is a worse outcome.

    at baseline, after 12 weeks, then after another 12 weeks. We will compare results of the intervention group at 12 and 24 weeks to their baseline.

  • PROMIS - anxiety

    PROMIS Short Form - anxiety scale. Scores of 8-40; Higher is a worse outcome.

    at baseline, after 12 weeks, then after another 12 weeks. We will compare results of the control group at 12 and 24 weeks to their baseline.

  • PROMIS - Depression

    PROMIS Short Form - Depression scale. Scores of 8-40; Higher is a worse outcome.

    at baseline, after 12 weeks, then after another 12 weeks. We will compare results of the intervention group at 12 and 24 weeks to their baseline.

  • PROMIS - Depression

    PROMIS Short Form - Depression scale. Scores of 8-40; Higher is a worse outcome.

    at baseline, after 12 weeks, then after another 12 weeks. We will compare results of the control group at 12 and 24 weeks to their baseline.

  • Resiliency

    Connor-Davidson Resiliency Scale. Scores of 0-40; Higher score is better.

    at baseline, after 12 weeks, then after another 12 weeks. We will compare results of the intervention group at 12 and 24 weeks to their baseline.

  • Resiliency

    Connor-Davidson Resiliency Scale. Scores of 0-40; Higher score is better.

    at baseline, after 12 weeks, then after another 12 weeks. We will compare results of the control group at 12 and 24 weeks to their baseline.

  • Stress scale

    Perceived Stress Score. Scores of 0-40; Higher score is worse.

    at baseline, after 12 weeks, then after another 12 weeks. We will compare results of the intervention group at 12 and 24 weeks to their baseline.

  • Stress scale

    Perceived Stress Score. Scores of 0-40; Higher score is worse.

    at baseline, after 12 weeks, then after another 12 weeks. We will compare results of the control group at 12 and 24 weeks to their baseline.

  • Usability

    Usability scale. Scores of 10-50; Higher score is better.

    after 12 weeks we will dertermine the usability of the VR intervention in the intervention group

Study Arms (2)

Intervention - VR Mindfulness

EXPERIMENTAL

The intervention group will be given the VR headset for their unrestricted use over the 12 week intervention period. The VR headset is exceptionally easy and intuitive to use. Each participant will have the choice of 20 "locations" in which to use the mindfulness-based program. Each of the 20 locations/programs are different. They range in length from 5 minutes (introductory) to 20 minutes.

Behavioral: VR mindfulness

Control

NO INTERVENTION

The control arm will not have any intervention. However, at the conclusion of the study, all participants from the Control group will be given the VR intervention

Interventions

VR mindfulnessBEHAVIORAL

VR-based mindfulness

Intervention - VR Mindfulness

Eligibility Criteria

Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • physician or APP employed by the Medical Group

You may not qualify if:

  • Not willing to receive 2 texts per week

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

UMassMemorial Health Care

Worcester, Massachusetts, 01655-0002, United States

Location

MeSH Terms

Conditions

Psychological Well-Being

Condition Hierarchy (Ancestors)

Personal SatisfactionBehavior

Study Officials

  • Steven Bird, MD

    University of Massachusetts, Worcester

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Emergency Medicine

Study Record Dates

First Submitted

January 30, 2024

First Posted

February 7, 2024

Study Start (Estimated)

June 1, 2026

Primary Completion (Estimated)

June 1, 2027

Study Completion (Estimated)

July 31, 2028

Last Updated

March 13, 2026

Record last verified: 2025-09

Data Sharing

IPD Sharing
Will not share

Locations